| 1. |
Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit care Med, 2007, 176: 532-555.
|
| 2. |
中華醫學會呼吸病學分會慢性阻塞性肺疾病學組. 慢性阻塞性肺疾病診治指南( 2007 年修訂版) . 中華結核和呼吸雜志,2007, 30: 8-17.
|
| 3. |
周營營, 朱蕾. 慢性阻塞性肺疾病的肺功能診斷標準不等同于阻塞性通氣功能障礙的診斷標準. 中國呼吸與危重監護雜志,2008, 7: 323-324.
|
| 4. |
朱蕾, 周營營. 回復《對阻塞性通氣功能障礙嚴重程度與慢性阻塞性肺疾病嚴重程度標準的疑惑》. 中華結核和呼吸雜志,2009, 32: 319-320.
|
| 5. |
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005, 26: 948-968.
|
| 6. |
朱蕾, 劉又寧, 于潤江, 主編. 臨床肺功能. 北京: 人民衛生出版社, 2004.
|
| 7. |
th ed. Chicago: AMA Press, 2000, 8.
|
| 8. |
朱蕾, 劉又寧, 鈕善福, 主編. 臨床呼吸生理學. 北京: 人民衛生出版社, 2008.
|
| 9. |
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005, 26: 948-968.
|
| 10. |
Cocchiarella L, Anderson GB. Guides to the evaluation of permanent impairment.
|
| 11. |
Menezes AM, Perez-Padilla R, JardimJR, et al. Chronic obstructive pulmonary disease in five Latin American cities ( the PLATINO study) : a prevalence study. Lancet, 2005, 26: 1875-1881.
|
| 12. |
Falaschetti E, Laiho J, Primatesta P, et al. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J, 2004, 23: 456-463.
|
| 13. |
周營營, 劉莉, 胡莉娟, 等. 采用一秒率的不同標準作為定性指標對慢性阻塞性肺疾病患病率的影響. 中國呼吸與危重監護雜志, 2009, 8: 16-18.
|
| 14. |
Roberts SD, Farber MO, Knox KS, et al. FEV1 /FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest,2006, 130: 200-206.
|
| 15. |
Pérez-Padilla R, Hallal PC, Vázquez-García JC, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD, 2007, 4: 113-120.
|
| 16. |
殷凱生, 孫培莉, 姚欣, 等. 回復《如何判斷支氣管舒張試驗陰性時對診斷支氣管哮喘的意義》. 中華結核和呼吸雜志, 2005,28: 852.
|
